4//SEC Filing
Smith L. Mary 4
Accession 0001104659-21-125932
CIK 0001773427other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 8:24 PM ET
Size
9.1 KB
Accession
0001104659-21-125932
Insider Transaction Report
Form 4
Smith L. Mary
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-10-13$2.30/sh+10,000$23,000→ 177,511 total - Sale
Common Stock
2021-10-13$55.97/sh−10,000$559,675→ 167,511 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-10-13−10,000→ 84,296 totalExercise: $2.30Exp: 2029-04-22→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.95 to $56.99, inclusive.
- [F3]Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
- [F4]This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001787013
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 8:24 PM ET
- Size
- 9.1 KB